Health Reference Library

What nutritional support helps with heavy periods and iron loss?

Last reviewed 29 April 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

Heavy menstrual bleeding (HMB) is the most common cause of iron deficiency in pre-menopausal women. NICE NG88 retired the 80 ml volumetric definition in favour of a quality-of-life-focused diagnosis. The nutritional protocol is dominated by one well-anchored intervention: iron replacement for the resulting deficiency. Other claims (ginger, zinc, vitamin A, omega-3, turmeric) have limited and mixed evidence and are not part of NICE NG88. The bleeding itself requires gynaecological assessment under NG88.

How it works

The iron deficiency caused by HMB is the well-anchored nutritional consequence requiring intervention. The bleeding itself is a gynaecological clinical question under NICE NG88 (Heavy menstrual bleeding: assessment and management, published 14 March 2018, last updated 24 May 2021), which covers history, examination, full blood count, and investigation for fibroids, adenomyosis, polyps, and coagulation disorders. Von Willebrand disease (the most common inherited bleeding disorder) is consistently underdiagnosed in women with lifelong HMB.

Effective dose

Continue iron 3 months past Hb normalisation. Endpoint is clinical (symptom resolution, restored stores), not a numerical ferritin target. Where oral iron has failed or is not tolerated and HMB continues to drive recurrent deficiency, parenteral iron is the BSG-supported next-line option. Tolkien 2015 (PLoS One 10(2):e0117383, PMID 25700159) anchors GI tolerability considerations.

Timing

The cyclical nature of HMB-related iron loss means iron status assessment timing should account for the current point in the menstrual cycle. If HMB is unaddressed, iron deficiency tends to recur. NICE NG88 management options for the bleeding itself include LNG-IUS (frequently first-line), tranexamic acid, NSAIDs, combined hormonal contraception, and surgical options where appropriate; nutritional supplementation is NOT part of the NG88 framework for the bleeding itself.

Safety profile

Iron supplementation in iron-replete individuals carries risk; iron status testing is appropriate before supplementation outside well-defined high-risk groups. Self-supplementation with iron without confirmed deficiency can be harmful, particularly in haemochromatosis or other iron-loading conditions. High-dose vitamin A specifically is teratogenic and contraindicated in pregnancy.

Special populations

Adolescents: ginger evidence comes from a small Iranian high school girl trial (Kashefi 2015) and does not extend to adult populations. Coagulation disorders (von Willebrand disease) are particularly underdiagnosed in women with lifelong HMB and warrant specialist evaluation. Inflammatory bowel disease, coeliac disease, and post-bariatric anatomy magnify malabsorption concerns; per BSG 2021, parenteral iron is supported in those contexts.

Interactions

Vitamin C does enhance non-haem iron absorption modestly. Hurrell and Egli 2010 (Am J Clin Nutr 91(5):1461S-1467S, PMID 20200263) clarified that single-meal isotope studies overstate the vitamin C effect compared with multi-meal whole-diet measurements. The popular framing of vitamin C doubling iron absorption overstates the practical clinical effect. BSG 2021 does not include routine vitamin C co-administration as a recommended intervention.

InteractionIssueGuidanceCitation
Iron and calciumCalcium reduces non-haem iron absorptionSeparate iron supplements from calcium-containing meals by around 2 hoursNICE — Heavy menstrual bleeding: assessment and management
Iron and vitamin CVitamin C enhances non-haem iron absorption (single-meal effect; long-term clinical benefit less reliable)Take iron with a vitamin C source such as orange juiceNICE — Heavy menstrual bleeding: assessment and management

Guideline positions

The Stoffel/Moretti programme (Moretti 2015 Blood 126(17):1981-1989, PMID 26289639; Stoffel 2017 Lancet Haematol 4(11):e524-e533, PMID 29032957) anchors the alternate-day dosing approach. Tolkien 2015 (PLoS One 10(2):e0117383, PMID 25700159) covers GI tolerability of ferrous sulphate. Hurrell and Egli 2010 (Am J Clin Nutr 91(5):1461S-1467S, PMID 20200263) anchors the vitamin C clarification. Kashefi 2015 (Phytother Res 29(1):114-119, PMID 25298352) is the small ginger RCT.

Practical framework

Where HMB is ongoing, the practical iron-loss-vs-iron-replacement balance often requires either ongoing supplementation or HMB-specific intervention per NG88. The nutritional consequence (iron deficiency) is one piece; the bleeding itself sits in NG88 clinical territory and warrants clinical assessment, not nutritional substitution. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: vitamin A, zinc, omega-3, or curcumin meaningfully treat heavy menstrual bleeding. Evidence base is limited and mixed; these are NOT part of mainstream UK clinical guidance for heavy menstrual bleeding. Specific online dose claims (vitamin A 25,000 IU, zinc 25 mg daily, omega-3 2-3 g) are not robustly anchored. Ginger has one small RCT in adolescents (Kashefi 2015) but is not part of NICE NG88. The honest framing: limited and mixed evidence; not in NICE NG88; iron deficiency is the well-anchored consequence requiring intervention.

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Recent updates

Reviewed and corrected against sources on ,

Sources

  1. National Institute for Health and Care Excellence (NICE) 2018. Heavy menstrual bleeding: assessment and management. National Institute for Health and Care Excellence (NICE).
  2. Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RPH, Pritchard DM, Sidhu R, Surgenor S, Thomas W, Verma AM 2021. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. PMID: 34497146 · DOI: 10.1136/gutjnl-2021-325210
  3. Camaschella C 2015. Iron-deficiency anemia. New England Journal of Medicine. PMID: 25946282 · DOI: 10.1056/nejmra1401038
  4. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB 2015. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. PMID: 26289639 · DOI: 10.1182/blood-2015-05-642223
  5. Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, Moretti D, Zimmermann MB 2017. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematology. PMID: 29032957 · DOI: 10.1016/s2352-3026(17)30182-5
  6. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ 2015. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. PMID: 25700159 · DOI: 10.1371/journal.pone.0117383
  7. Hurrell R, Egli I 2010. Iron bioavailability and dietary reference values. American Journal of Clinical Nutrition. PMID: 20200263 · DOI: 10.3945/ajcn.2010.28674f
  8. Kashefi F, Khajehei M, Alavinia M, Golmakani E, Asili J 2015. Effect of ginger (Zingiber officinale) on heavy menstrual bleeding: a placebo-controlled, randomized clinical trial. Phytotherapy Research. PMID: 25298352 · DOI: 10.1002/ptr.5235

Related entries

Back to Iron overview